Inhalation Sciences

ISAB has achieved robust growth for sales of its unique, high-precision platform technology and Inhalation Research Services (IRS), with a Q2 revenue increase of 36% compared to the same period last year, and a 500% growth in signed sales orders compared to the same period in the preceding year.

Manoush will be joining a host of other Nordic Life Science executives at the event.

Don't miss the opportunity to learn more about ISAB's recent achievements and developments - explore Life Science Day 2023 here: https://www.redeye.se/events/915984/redeye-life-science-day-2023?tab=attendingcompanies